OMVYA Trademark

Trademark Overview


On Friday, September 27, 2019, a trademark application was filed for OMVYA with the United States Patent and Trademark Office. The USPTO has given the OMVYA trademark a serial number of 88633438. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 13, 2023. This trademark is owned by Eli Lilly and Company. The OMVYA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis
omvya

General Information


Serial Number88633438
Word MarkOMVYA
Filing DateFriday, September 27, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 13, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 10, 2019

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 2, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Monday, March 13, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 13, 2023ABANDONMENT - NO USE STATEMENT FILED
Friday, July 29, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 28, 2022SOU EXTENSION 5 GRANTED
Monday, July 18, 2022SOU EXTENSION 5 FILED
Monday, July 18, 2022TEAS EXTENSION RECEIVED
Wednesday, January 26, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 25, 2022SOU EXTENSION 4 GRANTED
Tuesday, January 18, 2022SOU EXTENSION 4 FILED
Tuesday, January 18, 2022TEAS EXTENSION RECEIVED
Saturday, July 17, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 15, 2021SOU EXTENSION 3 GRANTED
Thursday, July 15, 2021SOU EXTENSION 3 FILED
Thursday, July 15, 2021TEAS EXTENSION RECEIVED
Thursday, January 21, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 19, 2021SOU EXTENSION 2 GRANTED
Tuesday, January 19, 2021SOU EXTENSION 2 FILED
Tuesday, January 19, 2021TEAS EXTENSION RECEIVED
Tuesday, August 11, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, August 8, 2020SOU EXTENSION 1 GRANTED
Monday, July 20, 2020SOU EXTENSION 1 FILED
Saturday, August 8, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, July 20, 2020TEAS EXTENSION RECEIVED
Tuesday, February 4, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 10, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 10, 2019PUBLISHED FOR OPPOSITION
Wednesday, November 20, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 31, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, October 26, 2019ASSIGNED TO EXAMINER
Wednesday, October 2, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 1, 2019NEW APPLICATION ENTERED